Skip to main content
  • Investor Relations
  • Contact Us

Leadership

The members of our leadership team have extensive experience in the biotechnology and pharmaceutical industry with proven track records in research and development, building high-science companies and creating value.
Breaking Boundaries Engineering The Future of Targeted Medicines
Leadership Board of Directors Scientific Advisors
Professor Dror Harats, headshot
Prof. Dror Harats, M.D.
Chief Executive Officer
Read More
Sam Backenroth headshot
Sam Backenroth
Chief Financial Officer
Read More
Erez Feige headshot
Erez Feige, Ph.D., M.B.A.
Senior Vice President, Business Operations
Read More
Naamit Sher headshot
Naamit Sher, Ph.D.
Senior Vice President, Development and Regulatory
Read More
Eyal Breitbart headshot
Eyal Breitbart, Ph.D.
Senior Vice President, Research & Operations
Read More
Tami Rachmilewitz headshot
Tami Rachmilewitz, M.D.
Senior Vice President, Clinical Development
Read More
Matt Trudeau headshot
Matt Trudeau, M.Sc.
Chief Commercial Officer
Read More
Amos Ron headshot
Amos Ron
Corporate Secretary
Read More
  • About Us
  • Technology & Pipeline
  • Patients & Caregivers
  • Investor Relations
  • Contact Us
VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late clinical stage biotechnology company committed to the discovery, development and commercialization of next-generation, targeted medicines for difficult-to-treat medical conditions. Our goal is to develop and provide safe, effective and life-improving medicines to people living with cancer and immune-inflammatory diseases.

We cordially invite our shareholders to attend an Annual General Meeting to be held at 4:00 PM (Israel time) on July 7. For further details see here.

Latest News

Copyright © 2022 VBL Therapeutics.
Terms and Conditions. Privacy Policy. Accessibility.